Dentsply International reported total Q4 revenue of $961 million, up 6.2% year-over-year, driven by $428 million from Europe (44.5% of total, +1.86% surprise) and $237 million from Rest of World (24.7% of total, -2.42% surprise). Comparisons to the prior quarter and year-ago period show steady international demand despite regional fluctuations.

Analysts project the next quarter’s revenue will decline 1.2% year-over-year to $868.6 million, with Europe forecasted at $379.7 million (43.7% of total) and Rest of World at $216.7 million (25%). For the full year, revenue is expected to fall 3.1% to $3.57 billion, with Europe contributing $1.61 billion and Rest of World $929.5 million.

Over the past four weeks, Dentsply’s shares have risen 17.2% versus a 1.3% gain in the S&P 500 and 2.6% gain in the medical sector; three-month performance shows a 28.9% increase versus 1% for the S&P 500 and 0.2% for the sector. The company holds a #3 (Hold) rating from its proprietary stock rating system, indicating potential to match market performance in the near term.